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1384Objective: We investigated the feasibility and accuracy of a novel surgical marking system based on radiofre-
quency identification (RFID) technology for the localization of small peripheral lung nodules (SPLNs) in
a canine model.
Methods: The system consists of 4 components: (1) micro RFID tags (13.56 MHz, 1.0 3 1.0 3 0.8 mm), (2)
a tag delivery system with a bronchoscope, (3) a wand-shaped locating probe (10-mm diameter), and (4) a signal
processing unit with audio interface. Before the operation, pseudolesions mimicking SPLNs were prepared in
7 dogs by injecting colored collagen. By use of a computed tomographic (CT) guide, an RFID tag was placed
via a bronchoscope close to each target lesion. This was then followed by scanning with the locating probe, and
wedge resection was performed when possible. Operators can locate the tag by following the sound emitted by
the system, which exhibits tone changes according to the tag-probe distance. The primary outcome measure was
the rate of wedge resection with good margins.
Results: A total of 10 pseudolesions imitating SPLNs were selected as targets. During thoracoscopic proce-
dures, 9 of 10 tags were detected by the systemwithin a median of 27 seconds.Wedge resections were performed
for these 9 lesions with a median margin of 11 mm. The single failurewas caused by tag dislocation to the central
airway.
Conclusions: Successful localization and wedge resection of pseudolesions with appropriate margins were ac-
complished in an experimental setting. Our RFIDmarking system has future applications for accurately locating
SPLNs in a clinical setting. (J Thorac Cardiovasc Surg 2014;147:1384-9)Video clip is available online.
The accurate localization of small peripheral lung nodules
(SPLNs) in a thoracoscopic setting is a challenging task,
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The Journal of Thoracic and Cardiovascular Surimportance of minimally invasive surgical procedures has
increased in recent years. In 2010, the rate of video-
assisted thoracic surgery reportedly reached nearly 60%
of lung cancer surgery in Japan2 and 44.7% in the United
States.3 The vast majority of SPLNs are therefore likely
to be resected by a thoracoscopic approach in Japan.
Many techniques to assist the localization of SPLNs have
been developed and reported; these include finger palpa-
tion, percutaneous hook-wire placement, preoperative dye
marking, fluoroscopy with a contrast medium, intraopera-
tive ultrasonography (US), and radiotracer-guided surgery.4
These techniques have proved reliable to a certain extent,
but all possess considerable problems in complications,
cost, technical difficulty, and availability of facilities.5 Con-
sequently, there is not yet an established ‘‘best technique,’’
and the choice of method is highly dependent on each sur-
geon’s preference.
Despite the lack of a definitive solution for determining
SPLN location, thoracic surgeons are required to manage
an increasing number of small pulmonary nodules owing
to the continued improvement of computed tomography
(CT) technology. In 2011, the National Lung Screening
Trial established the ability of low-dose CT screening to
reduce mortality in a high-risk population.6 Also, recent
guidelines for lung cancer screening from The Americangery c April 2014
Abbreviations and Acronyms
CT ¼ computed tomography
RFID ¼ radiofrequency identification
SPLN ¼ small peripheral lung nodule
US ¼ ultrasonography
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surgical excision of subcentimeter lesions in patients whose
tumors show suspicious changes in size or appearance.7 For
years, the preoperative marking for lung nodules smaller
than 10 mm in size has also been recommended.8 In light
of these advances in CT screening and recommendations,
there is an unprecedented need to improve localization
techniques.
Furthermore, in this era of minimally invasive surgery,
there is an increasing demand for innovative localization
techniques. An ideal method not only would ensure patient
safety but also would allow for adequate minimum margins
from the lesion. For instance, maintenance of appropriate
margins for sublobar curative resection of primary lung
cancer has been shown to reduce recurrences.9 The impor-
tance of appropriate margins has similarly been emphasized
in the resection of metastatic pulmonary nodules to prevent
local recurrence.10 However, for surgeons to ensure
adequate margins, they must first be able to gauge the exact
distance from the target lesion to the cutting line for
resection.
To address these problems, we have proposed a novel sur-
gical marking system based on radiofrequency identifica-
tion (RFID) technology, which provides a precise ranging
ability.11 In our system, 13.56-MHz micro RFID tags are
used as ‘‘wireless surgical markers’’ to label lesions that
are otherwise difficult to locate. In this study, we test the
feasibility and reliability of this RFID marking system us-
ing experiments with pseudolesions imitating SPLNs in
a canine model.E
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RFID Marking System
The schematic diagram of our proposed RFID marking system is shown
in Figure 1. The entire system consists of the following 4main components:
(1) micro RFID tags coated with polyester resin (13.56 MHz,
1.03 1.03 0.8 mm; Star Engineering Co, Ltd, Singapore), (2) tag delivery
system with bronchoscope, (3) wand-shaped locating probe (10-mm diam-
eter), and (4) signal processing unit with audio interface.
The detailed composition and algorithms of the system have been re-
ported in our previous article.11 The micro RFID tag works as a passive
transponder without a built-in battery, with the locating probe acting as
both a power supply coil and a receiver antenna. When the probe is placed
in close proximity to the tag, the tag is activated by the electromagnetic field
produced by the probe. The activated tag returns the response signal with
a fixed wavelength of 13.56 0.423MHz. The distance between the probe
and the target tag is measured by signal strength and visually presented on
a monitor. The signal strength is also converted to a corresponding audioThe Journal of Thoracic and Cartone by the signal processing units. The operator can then accurately locate
the implanted tags by scanning the target areawith the probe and reacting to
changes in the tone; when the probe is placed closer to the tag, the system
produces a higher pitch. The prototype system used in this animal experi-
ment had an effective range of measurement of 7 mm, and the distance
can be measured down to the millimeter level.
Animal Care
Animal care, housing, and surgery were performed with the approval of
the Committee for Animal Research of Kyoto University, Japan, which en-
sures the humane treatment of laboratory animals in compliance with
guidelines established by the Ministry of Education, Culture, Sports,
Science and Technology, Japan. Seven dogs (age,<2 years; body weight,
7.5-12.5 kg) were used in this study. Before the bronchoscopic procedures,
all dogs were premedicated by intramuscular injection of 0.05 mg/kg
atropine sulfate. They were then sedated with intramuscular injection of
15 mg/kg ketamine hydrochloride and 3 mg/kg xylazine hydrochloride.
Local anesthesia of the upper respiratory tract was performed using
a 1% lidocaine solution. For surgical procedures, dogs were intubated en-
dotracheally under the same premedication and anesthetic sedation. Sevo-
flurane and nitrous gas were used for maintenance of anesthesia, under
mechanical ventilation. Electrocardiogram and percutaneous oxygen satu-
ration were monitored throughout the surgical procedures.
Preparation of SPLN-Imitating Pseudolesions and
Selection of Target Lesions
Before the operation, pseudolesions imitating SPLNs were created by in-
jecting 0.2 mL of colored collagen to lung peripheral parenchyma in a se-
lected variety of lobes under CT guidance (Aquilion TSX-101A; Toshiba,
Tokyo, Japan). The colored collagen solution was prepared as a mixture
of 5 mL of 1% collagen solution and 5 mL of dye (5% indocyanine green
or indigocarmine). A 23-gauge injection needle (NM-201L-0423; Olympus
Corporation, Tokyo, Japan) was used for injecting the solution through the
working channel of the bronchoscope (BF240; Olympus). A postprocedure
CT scan was performed to confirm the size and location of each created
lesion. Peripherally located pseudolesions with a diameter of approximately
10 mm were selected as target lesions for further experimentation.
Marking of the Target Lesions
The target lesions were marked within 2 days after creation for the sub-
sequent operative procedures. Under a CT scan guide, an RFID tag was de-
livered into a small peripheral airway close to each target lesion. Through
the 2-mm working channel of the bronchoscope, an introducer tube with
a radiopaque marker on its distal tip was navigated to the target lesion
(Figure 2). The tube was constructed from polytetrafluoroethylene (Teflon;
DuPont Corporation, Wilmington, Del) and has an outer diameter of 1.8
mm. When the operator confirmed that the tip of the introducer tube was
in the vicinity of the target lesion, the tag could then be implanted: the
RFID tag was inserted from the proximal end of the tube and pushed out
from the distal end by a flexible pusher-wire made of stainless steel. A post-
procedure CT scan was performed to measure the distance from the tag to
the nearest edge of the target lesion.
Operative Procedure
Immediately after tag delivery to the target lesions, the dogs were
brought into an operating room and placed in a lateral decubitus position.
With the animals under general anesthesia with intubation and ipsilateral
lung collapse, the embedded tag and wedge resection of the target lesion
were detected. Three ports with a 10-mm incision were set for each
tag—1 for the scope and 2 for port access to the pleural cavity. Under thor-
acoscopic view, the lobe of interest was scanned with the locating probe to
find the target lesion labeled with the tag. When the tag was localized, ring-
shaped forceps were introduced from the other port to grasp the pleura justdiovascular Surgery c Volume 147, Number 4 1385
FIGURE 1. A, Photograph of a micro radiofrequency identification (RFID) tag on a forefinger (scale bar¼ 1 mm). The tag works as a passive transponder
when it is activated by a radio wave of 13.56 MHz. B, Schematic diagram of the RFID marking system, including a wand-shaped locating probe for endo-
scopic use and a signal processing unit with an audio interface. The operator can locate the implanted tags by scanning the target area with the probe and
responding to audio cues; when the probe is nearer the tag, the system produces a higher pitch.
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was pulled off and an endostapler was introduced from the same port to
clamp the estimated resection line. Before the endostapler was fired, the
locating probe was reinserted in place of the ring forceps to establish
that the tag was contained within the lung tissue to be excised (Figure 3).
Owing to the millimeter-level ranging capability of the system, an appro-
priate surgical margin could be ensured. When the lesion and the tag
were resected with the endostaplers, the specimen was incised to measure
the surgical margin.
Outcome Measures
The primary end point of this study was the rate of successful wedge re-
section of pseudolesions with good margins. Secondary measures were (1)FIGURE 2. Illustration of the radiofrequency identification (RFID) tag
delivery system. An introducer tube with a radiopaque marker on its distal
tip is inserted through the 2-mm channel of a bronchoscope. The material
of the tube is polytetrafluoroethylene (Teflon). An RFID tag is inserted
from the proximal end of the tube and pushed out from the distal end by
a pusher-wire.
1386 The Journal of Thoracic and Cardiovascular Surthe distance from the pseudolesion to the tag as shown in the confirmation
CT, (2) the time required for the marking procedure, (3) the time required
for tag detection at operation, and (4) the distance from the edge of the
pseudolesion to the stapler line, which provides information on the surgical
margins (Table 1). The median values and range were calculated for these
measures. Finally, we analyzed the system’s merits and pitfalls.
RESULTS
A total of 14 pseudolesions were created by colored col-
lagen injection in 7 dogs. Of the 14 pseudolesions, 10 had
a diameter of approximately 10 mm and were selected as
target lesions for further experimentation; there were 2
pseudolesions located in the right cranial lobes, 4 in the
right caudal lobes, and 4 in the left caudal lobes. The other
4 pseudolesions were excluded because of larger diffusion
or intrabronchial spread of injected collagen solution.
By means of the bronchoscopic marking procedures,
each selected pseudolesion was accurately labeled with 1FIGURE 3. Thoracoscopic view of tag detection with a locating probe
(LP) and resection of a pseudolesion in peripheral lung parenchyma. Be-
fore firing off the endostapler (ES), the operator can confirm the position
of the implanted tag to ensure an appropriate margin.
gery c April 2014
TABLE 1. Results of the primary end point and secondary outcome
measures of the experiments
Primary end point
Successful tag detection* 9/10
Successful wedge resection* 9/10
Secondary measures Median
Time required for marking (min) 5-34 11
Distance from the lesion to the tag (mm) 0-6.5 2.1
Time required for tag detection (s)y 10-105 27
Surgical margin (mm)y 8-12 11
*One failure was due to dislocation of the tag. yn ¼ 9.
Kojima et al Evolving Technology/Basic ScienceRFID tag (Figure 4). The tags were placed at a median dis-
tance of 2.1 mm from the lesions (range, 0-6.5 mm, con-
firmed by postprocedure CT scan). The time required for
the marking procedure ranged from 5 to 34 minutes (me-
dian, 11 minutes) from the insertion of the bronchoscope
to the completion of the confirmation CT scan. Marking
procedures were performed just after the creation and selec-
tion of the first 3 target pseudolesions and 1 or 2 days after
creation for the other 7. No major complications such as
pneumothorax or bleeding were observed.
During the thoracoscopic surgical procedures, 9 of the 10
implanted tags were successfully detected by the system.
The time required for detection ranged from 10 to 105 sec-
onds (median, 27 seconds). Subsequently, wedge resections
were performed for these 9 lesions with a median margin of
11 mm (range, 8-12 mm). In the single nondetected case,
a right upper lobectomy was performed only to find no
tag in the resected lobe. The dislocated tag was later found
in the endotracheal tube.DISCUSSION
RFID is a wireless method of automatic identification
originally developed for military radar systems in the
1940s to distinguish between friendly and enemy aircraft.12FIGURE 4. A, Computed tomography scan of a canine lung, including a pseu
dotted line) and an implantedmicro radiofrequency identification tag (black arro
The Journal of Thoracic and CarCurrently, RFID tags are indispensable in modern society,
with applications in item tracking for supply chain manage-
ment, cashless payments for shopping, and personal identi-
fication for ticketing or entrance gates. The continuing
miniaturization of RFID tags and development of computer
networks have contributed to the widespread use of this
system.
Applications have also developed in the field of health
care: RFID technology has become widely used for
personal identification of medical staff and for tracking
drugs and medical equipment in so-called ‘‘smart hospi-
tals.’’13 Some reports have been published in which RFID
technology was deployed to solve problems specific to
medical practice. For example, Macario and colleagues14
successfully detected surgical sponges labeled with RFID
tags in the abdomen, Reicher and colleagues15 reported
the efficacious monitoring of the position of an RFID
tag–labeled endotracheal tube at bedside, and Mayse
and colleagues16 experimentally implanted RFID tags in
canine airways to achieve real-time tracking of tumor
positions for stereotactic radiotherapy. In all these medical
cases, RFID technology was used to detect the position of
an embedded tag.
Our idea was to use micro RFID tags as wireless markers
for locating SPLNs in thoracoscopic lung surgery. There is
currently only a single previous report showing a similar
concept in the field of breast surgery.17 That study was
essentially a proof of concept in a phantom study using
large-sized tags (2 mm in diameter and 8 or 12 mm in
length) responding to a radiofrequency of 134.2 kHz. To
our knowledge, there has been no report on animal experi-
ments or clinical trials of the system, although their tags
(VeriChip; Verimed, Inc, Fort Lauderdale, Fla) have been
approved by the United States Food and Drug Administra-
tion for human use. With the further advances in RFID tech-
nology, we have used 1-mm RFID tags in this study and
confirmed their feasibility in an animal model for lung
wedge resection.dolesion created by colored collagen injection (areas surrounded by black
w). B, Photograph of a corresponding surgical specimen (scale bar¼ 1mm).
diovascular Surgery c Volume 147, Number 4 1387
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era of open thoracotomies. It is evenmore difficult in a thor-
acoscopic situation because finger palpation is far less ef-
fective. As a consequence, many techniques to assist in
the localization of SPLNs have been innovated, with these
techniques broadly belonging to 1 of 2 completely different
strategies: intraoperative techniques (eg, finger palpation
and ultrasound) and preoperative placement of a marker
(eg, hook-wire, dye, contrast medium, and radiotracer).4
Intraoperative techniques have the virtue of noninvasive-
ness, and to our knowledge no major complications as a re-
sult of these techniques have been reported. Even though
intraoperative US is more effective than finger palpation,
with a success rate of 70% to 100% in selected patients,4
this technique has several limitations.5 Successful localiza-
tion using intraoperativeUS is highly dependent on operator
skill. Also, localization is difficult in cases of emphysema-
tous change or incomplete collapse of the target lung. Suc-
cess rates are further reduced in cases of small nodules less
than 1 cm in size or deep lesions more than 1 cm from the
visceral pleura. Soft nodular ground-glass opacities ob-
served in bronchoalveolar cell carcinomas are also difficult
to localize using US. Because of these limitations, intrao-
perative US has little versatility as a localization technique.
The use of markers is a viable option for surgeons to over-
come the limitations of intraoperative localization tech-
niques. The implantation or delivery procedures of several
kinds of markers can be classified into 2 categories accord-
ing to their approaches: a percutaneous pneumocentesis ap-
proach and a transbronchial approach with a bronchoscope.
Generally, percutaneous implantation of a marker is highly
associated with complications such as pneumothorax (8%–
50%), pulmonary hemorrhage (12%–35%), and pleuritic
pain (5%–6%).4 In addition, several authors have raised
caution on the risk of fatal air embolisms induced by
hook-wire implantation.18 In contrast, the transbronchial
approach can theoretically eliminate the risk of complica-
tions related to the percutaneous approach. In our experi-
ments, no major complications were observed related to
bronchoscopic delivery of RFID tags, and the time required
for marking ranged from 5 to 34 minutes (median, 11 min-
utes). Bronchoscopic procedures can be a distressing expe-
rience for patients, but the transbronchial approach is less
invasive than the percutaneous approach.
However, some markers have been used despite their
negative aspects. Time constraints are the main cause of
failure in the case of dye or radiotracer marking, as the dif-
fusion of dyes and the decay of radiotracers prevent sur-
geons from successful localization of SPLNs. These
shortcomings also lead to difficulties in scheduling preoper-
ative procedures and surgical resection. It has been recom-
mended that surgery be performed within 24 hours after
injection of dye and within 12 hours after radiotracer ad-
ministration.4,5 The RFID marking system is free from1388 The Journal of Thoracic and Cardiovascular Surthese time constraints and can provide flexibility in the
time interval between the marking procedure and surgery.
In the context of intraoperative fluoroscopy, a contrast
medium (ie, barium or lipiodol) is consistently reported as
the most effective and reliable marker: Watanabe and col-
leagues19 reported a success rate of 100% from their expe-
rience of 174 nodules; Asano and associates20 emphasized
a success rate of 100% for 31 pure ground-glass nodules
less than 10 mm in size; and Okumura and coworkers21
stated that good surgical margins could be assured with
this technique and that multiple markings can be achieved
by transbronchial injection of barium with minimum inva-
siveness. Unfortunately, despite these merits, the radiation
exposure for operators and patients cannot be overlooked.
Unnecessary exposure to medical radiation should be
avoided if possible, and the use of RFID technology pres-
ents an alternative for the purpose of SPLN localization.
The RFID marking system has several positive aspects.
The first merit is that of quick detection with simple opera-
bility. The system requires only a locating probe in the sur-
gical field. During thoracoscopic surgical procedures,
localization of the RFID tag was promptly achieved without
the need for unwieldy instruments such as a fluoroscope. As
shown in our experiments, the time required for tag detec-
tion after insertion of the locating probe ranged from 10
to 105 seconds (median, 27 seconds). Quick detection of
the tag and swift localization of the target lesion were
achieved by simply listening and reacting to the audio
cues from the system; there was no need for operators to
shift their gaze from the surgical field or the monitor for
the thoracoscope. The simple operability of the system
also exempts thoracic surgeons from having to become
skilled in an unfamiliar technique such as US interpretation
or from the threat of radiation exposure. The second and
more important merit is that the 1-mm small wireless
marker enables the pinpoint localization of target lesions;
the system provides millimeter-level ranging capability to
enhance localization accuracy. As a consequence, an appro-
priate distance from the lesion to the resection line is en-
sured because the operator can confirm that the RFID
marker is included within the lung parenchyma to be re-
sected. In our study with pseudolesions, surgical margins
of resected specimens ranged from 8 to 12 mm (median,
11 mm). Accurate localization enables thoracic surgeons
to perform sublobar resections with reduced risk of local re-
currence in a short procedure time. Third, the labeling of
multiple lesions or multiple marking of a single lesion can
be achieved in this system because each tag has its own
unique identifiable number.
This study has the following limitations. Our prototype
system has an effective communication range of 7 mm,
mainly owing to limitations in the power supply from the
locating probe. Although 7 mm is adequate for animal ex-
periments, an effective range of 30 mm may be requiredgery c April 2014
Kojima et al Evolving Technology/Basic Sciencefor clinical use in human lungs. Improvements to the effec-
tive range are in progress and can be achieved with further
customization of the tag and the probe.
The second limitation is that dislocation of the implanted
tag is a problem of critical importance for the RFIDmarking
system. The reason for the sole detection failure in our exper-
iments was the dislocation of the tag to the central airway. To
address this problem, we are developing a tag anchoring
function. For the purpose of lung tumor tracking during radi-
ation therapy, the use of anRFID tagwith anchoring legswas
reported to have an 87% successful stabilization rate for
a period of 60 days.22 In addition to the anchoring function,
the coating of RFID tags is another modification under con-
sideration owing to the possibility of accidental ingestion of
a dislocated tag into the digestive tract.
The third limitation is related to the safety of the system.
We did not encounter any instances of adverse effects caused
by the tag, but the study period was limited to 3 days at its
longest. The safety of the in vivo use of RFID tags has
been endorsed by long-term experiments in a canine
subcutaneous implantation model,23 as well as by routine
use in livestock farming. Although we have had limited
experience with RFID tag placement into a small airway,
Mayse and coworkers16 have reported no complications in
similar experimental implantation of 60 days. To our know-
ledge, no other published report has described the long-term
implantation effects of RFID tags into airways. Further
investigation is therefore required into the safety of this
system.
The additional cost, time, and radiation exposure could
be a demerit of this new method. However, the preoperative
marking procedure under CT guidance may be appropriate
for cases in which the target is a small peripheral lesion that
is difficult to locate under fluoroscopy. RFID tags in com-
mercial mass production are expected to be similar in cost
to conventional markers including hook-wires or dye. In
general, we estimate that the additional cost, time, and radi-
ation exposure for the RFID marking method are expected
to be in the same range as conventional methods that require
CT guidance. A cost-benefit analysis is required to deter-
mine the best role and use of such techniques in the manage-
ment of small peripheral lung nodules.E
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SCONCLUSIONS
The feasibility of our RFID marking system for SPLN lo-
calization was demonstrated in a canine model. Further de-
velopmental work is underway to improve the effective
range, to equip the tags with an anchoring function, and
to confirm the safety in implantation.
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